SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-006322
Filing Date
2018-05-07
Accepted
2018-05-07 13:50:41
Documents
5
Period of Report
2018-05-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 31695
2 ex10-1.htm EX-10.1 124341
3 image_001.jpg GRAPHIC 36767
4 image_002.jpg GRAPHIC 40396
5 image_003.jpg GRAPHIC 49133
  Complete submission text file 0001493152-18-006322.txt   331704
Mailing Address 11757 KATY FREEWAY, SUITE 1300-A HOUSTON TX 77079
Business Address 11757 KATY FREEWAY, SUITE 1300-A HOUSTON TX 77079 (281) 668-2666
Luckwel Pharmaceuticals Inc. (Filer) CIK: 0001567098 (see all company filings)

IRS No.: 461660653 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 333-187874 | Film No.: 18810597
SIC: 2834 Pharmaceutical Preparations